Source: Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Francesco Amati, Edoardo Simonetta, Andrea Gramegna, Paolo Tarsia, Martina Contarini, Francesco Blasi, Stefano Aliberti. The biology of pulmonary exacerbations in bronchiectasis. Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019

Member's Comments

No comment yet.

Related content which might interest you: A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 GORD/PPI and exacerbations in adults with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Pulmonary rehabilitation and exacerbations of COPD Source: Eur Respir Monogr 2021; 93: 165-181 Year: 2021 The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 COPD and other pulmonary diseases Source: Eur Respir Monogr 2015; 67: 161-178 Year: 2015 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019 Year: 2019 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Impact of exacerbations on COPD Source: Eur Respir Rev 2009; 19: 113-118 Year: 2010 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Pulmonary hypertension at the patients with bronchial asthma and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 58s Year: 2004 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 The challenge of defining exacerbation in bronchiectasis Source: Eur Respir J, 49 (6) 1700700; 10.1183/13993003.00700-2017 Year: 2017 Definition and aetiology of infective exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 58-67 Year: 2013 Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013